moxifloxacin has been researched along with viloxazine in 2 studies
| Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (viloxazine) | Trials (viloxazine) | Recent Studies (post-2010) (viloxazine) |
|---|---|---|---|---|---|
| 3,157 | 552 | 1,690 | 246 | 65 | 27 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Adewole, T; Busse, GD; Faison, SL; Fava, M; Kleiman, RB; Liranso, T; Nasser, A; Schwabe, S | 1 |
1 trial(s) available for moxifloxacin and viloxazine
| Article | Year |
|---|---|
Evaluation of the Effect of SPN-812 (Viloxazine Extended-Release) on QTc Interval in Healthy Adults.
Topics: Adrenergic Uptake Inhibitors; Adult; Cross-Over Studies; Delayed-Action Preparations; Double-Blind Method; Electrocardiography; Female; Heart Rate; Humans; Male; Moxifloxacin; Topoisomerase II Inhibitors; Viloxazine | 2020 |
1 other study(ies) available for moxifloxacin and viloxazine
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |